Epidermal growth factor receptor (EGFR), a tyrosine kinases receptor (RTK) belongs to the ErbB family, has been found to be over-expressed in many types of cancer, making it a typical target for cancer therapy (Salomon et al., 1995; Mendelsohn & Baselga, 2000). This evidence concerns the gene NTRK1 and cancer.